Cellular Therapy Near Columbus, OH

Chronic obstructive pulmonary disease (COPD) sufferers in the Columbus area have a new option for treatment without having to buy an airline ticket. At only 3-hours’ drive from Columbus, Pittsburgh, PA, offers more than the opportunity for cutting-edge medical treatment. Pittsburgh boasts prestigious healthcare facilities, but with its interesting and distinctive steel industry history, fine dining, and great places to stay, Pittsburgh is an up-and-coming destination for medical tourism.  Pittsburgh offers attractive options not only for the treatment of debilitating lung conditions, but also for a short vacation in a beautiful and historic Midwestern city.

Treating Lung Disease with Cells

Lung disease is the third leading cause of death in the United States, and most traditional treatment options only treat the symptoms rather than the disease itself. Most who have been diagnosed with lung disease are prescribed a bronchodilator and daily medication to clear the respiratory path and reduce coughing. The advent of cellular therapy is a game-changer for those with lung disease.

To date the Lung Institute has treated over 1,000 patients with cellular therapy, and is excited to increase the number of improved lives with the addition of the Pittsburgh Clinic. Dr. Jack Coleman, Jr, MD, is the Medical Director for the Lung Institute in Pittsburgh. He earned his medical degree from the University of Cincinnati as well as completed his internship and general surgery residency at the institution. Dr. Coleman is a board certified in physician and ensures that all treatments and staff will follow strict standards with the highest excellence in personalized patient care.

What is a Stem Cell?

Cells are the building blocks of life; they are essential to every living organism. They are able to self-renew and replicate—with the ability to form every type of tissue or organ in the body. Cells from one organ are able to create tissue for another organ; this is called plasticity. This is key to their function in regenerative medicine.

How Does the Lung Institute use Cells?

The Lung Institute offers cellular therapys for many of the major pulmonary conditions, including chronic obstructive pulmonary disorder (COPD), emphysemachronic bronchitispulmonary fibrosis and interstitial lung disease. The cells used by the Lung Institute are autologous, which means they come from the patient’s own body. The cells are extracted from the patient’s own blood. Cells have the capacity to form many types of differentiated cells, so when the cells are returned to the patient, they will target the damaged tissue, which leads to improved lung function in patients with a chronic lung disease. Our minimally invasive, outpatient cellular therapy are changing lives by helping patients breathe easier.

Why Choose the Lung Institute?

At the Lung Institute, we recognize the challenges of finding effective and sustainable treatment options for patients who might be suffering from debilitating lung diseases such as chronic obstructive pulmonary disease (COPD)pulmonary fibrosis, or interstitial lung disease. By harnessing the body’s innate healing capacity, we have developed revolutionary, minimally invasive cellular therapies to help treat lung disease. Our goal is to help patients breathe easier, improve their quality of life and provide hope.

Multiple Treatment Facilities

With facilities in TampaNashvilleScottsdale and Pittsburgh, our patients can choose from any of these locations for their cellular therapy. By applying modern-day best practices to the growing field of regenerative medicine, the Lung Institute is improving lives.

If you would like to find out more about our available treatment options, please contact one of our patient care coordinators today at (800) 729-3065 to schedule a free consultation.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.